Rapid antimicrobial susceptibility testing (AST) with true minimum inhibitory concentration (MIC) results – why is this technology valuable?

Rapid sepsis diagnostics have been discussed for multiple years now, and the impact of having a rapid result is clear. What is the current state in Europe? How does the ASTar technology bring added value to the microbiology lab, and what is the potential impact on the patient? This webinar will share experience and best practices on a new rapid technology.

Key learning objectives

• Explore current sepsis diagnostics and associated hurdles
• Discover what a rapid, true minimum inhibitory concentration (MIC) result direct from a positive blood culture brings to the lab and the patient
• Learn about the user's experience with different AST platforms and types of tests

Who should attend?

• Clinical microbiology laboratories/lab managers
• Infectious disease clinicians
• Medical technologists (Europe only)

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.